|
|
|
|
A computer program developed at MIT could vastly improve the design of antibody drugs. The software identified improvements in the anticancer drug cetuximab that increased its binding affinity by a factor of 10 in subsequent laboratory tests--a change that could lead to lower drug dosages and increased drug efficacy.
|
|
|
|
|
|
|
No link or resource associated with this scan
|
|
|
|
|